Position in LEGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,190,792
-$240,265 QoQ
Shares Held
65,826
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Derivatives in LEGN
reported options exposure · as of Jun 30, 2023CallValue
$966,420
CallShares
14,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in LEGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,190,792 | 65,826 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,431,057 | 65,826 | Shares | Other | 2026-02-17 | |
| 2024-06-30 | $1,324,492 | 29,905 | Shares | Other | 2024-08-14 | |
| 2023-06-30 | $966,420 | 14,000 | Call | Other | 2023-08-14 | |
| 2023-06-30 | $382,840 | 5,546 | Shares | Other | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||